Developer of a health monitoring system designed to facilitate self-health diagnosis.
Developer of a health monitoring system designed to facilitate self-health diagnosis.
Monitoring Equipment📍 Menlo Park, CAFounded 2013
Current Valuation
$600M
as of 2022-Q2
PRIVATE
QL Price
$402.65M
-33% vs last round
QuantLogix's current estimate for Hello Heart, published 2026-09-27 — below the last disclosed round of $600M (2022-Q2).
Confidence
medium
Basis
secondary led
What backs this price
Last disclosed round
$600M
2022-Q2
weight 0.05
Secondary market print
$384.6M
2026-06-27
weight 0.58
How this price has held up
No round has priced for Hello Heart since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-09-27 and will be graded against the next priced round. See the full accuracy record →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, Hello Heart, 2026-09-27 (b1e8c5c7887ac988).
The id pins this exact claim, so a citation stays checkable after the price moves.
Model estimate for research — not a quote, target price, or investment advice.
IPO Outlookprivate
Is Hello Heart going public?
No. Hello Heart is private and has not filed to go public. There is no S-1 on file.
What is Hello Heart's valuation in 2026?
Hello Heart is valued at $600M as of 2022-Q2, set by its Series D ($70M, May 2022). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Hello Heart filed an S-1?
No public S-1 is on file for Hello Heart.
How much has Hello Heart raised?
Hello Heart has raised $141.58M in total, most recently a Series D of $70M in May 2022.
Is Hello Heart publicly traded — can you buy Hello Heart stock?
No. Hello Heart is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Hello Heart on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
Founded
2013
HQ
Menlo Park, CA
Employees
440
Total Raised
$141.58M
Last Round
Series D — $70M (May 2022)
IPO Status
private
Fundraising Status
Series D · $70M · 4y 4mo ago
privateTotal raised $141.58M
Secondary Market
Implied price / share
$4.75
Last round price / share
$7.41
vs last round
-35.9%
Last round price vs secondary price
Secondary price return by period
Implied per-share price from private secondary transactions, as of Jun 2026. This is a point estimate, not a quote — the feed carries no bid, ask or spread, and a secondary print is evidence of what someone paid on that date rather than a live market. Compare across every tracked name →
Latest Funding Round
Round
Amount
Date
Lead Investor
Post-Money
Series D
$70M
May 2022
—
$600M
Talent Signal
Hiring trend
▲ Hiring uptrend
+18% vs 2026-08
Open roles
13
via greenhouse
Product-build share
46%
engineering, research, product, design
Trajectory
expanding
product-led hiring — 46% of open roles build product; the rest are go-to-market and G&A.
No tracked executive churn; open roles trending up.
Counted from Hello Heart's live job board as of 2026-09-16; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
MedicalHealth CareFitnessWellnessmHealth
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2022-Q2. Refreshed quarterly.